In our data, we detected statistically significant differences in total testosterone level (mean total testosterone levels 43,9± 43,9 ng/ dl in HH group vs. 524.6± 275,1 ng/dl in control group, respectively, p=0.000).
Results
In our data, we detected statistically significant differences in total testosterone level (mean total testosterone levels 43,9± 43,9 ng/ dl in HH group vs. 524.6± 275,1 ng/dl in control group, respectively, p=0.000).
There was no statistically a significant difference between HH group and control group interms of mean HDL-C (49,3±16,6 mg/ dl in HH group vs. 46,7±8,3 mg/ dl in control group, respectively, p=0,7), monocyte count ( mean monocyte count 0,5±0,3/ mm³ in HH group vs. 0,6±0,2 / mm³ in control group, respectively, p=0,2) and MHR( mean MHR 0,015±0,014 in HH group vs. 0,081±0,4 in contol group, respectively, p= 0,57). MHR also was not correlated with hematological parameters and total testosterone.
Conclusion
Previous studies have shown that, IHH patients with low testosterone levels, leading to impaired glucose metabolism,and increased cardiovascular risk . MHR also has been shown to be an indicator of cardiovascular risk in previous studies. But we did not any detect in MHR value in our patients with IHH. Therefore we do not suggest to calculate of monocyte count/ HDL cholesterol ratio for determinig of cardiovascular risk in men. .
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